Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-center Prospective Study to Assess the Safety and Effectiveness of Medi-Tate i-Temporary Implantable Nitinol Device (iTind) in Subjects With Symptomatic Benign Prostatic Hyperplasia (BPH)

NCT02506465 is registered in ClinicalTrials.gov with Medi-Tate Ltd. as lead sponsor.

NCT NCT02506465
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02506465 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-center Prospective Study to Assess the Safety and Effectiveness of Medi-Tate i-Temporary Implantable Nitinol Device (iTind) in Subjects With Symptomatic Benign Prostatic Hyperplasia (BPH)
Lead sponsor
Medi-Tate Ltd.
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2015
Completion date
October 31, 2018
Enrollment
185 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostate hyperplasia